SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-17-003392
Filing Date
2017-12-26
Accepted
2017-12-26 16:15:29
Documents
3
Period of Report
2017-12-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT peregrine_8k-122217.htm 8-K 24711
2 PRESS RELEASE peregrine_8k-ex9901.htm EX-99.1 13072
3 GRAPHIC image_001.jpg GRAPHIC 5080
  Complete submission text file 0001683168-17-003392.txt   46341
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-32839 | Film No.: 171274539
SIC: 2834 Pharmaceutical Preparations